Moore JC - Search Results

1

The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.

Carrier M, Knoll GA, Kovacs MJ, Moore JC, Fergusson D, Rodger MA. Carrier M, et al. Among authors: moore jc. Thromb Res. 2007;120(2):215-20. doi: 10.1016/j.thromres.2006.09.014. Epub 2006 Nov 13. Thromb Res. 2007. PMID: 17098277

2

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Warkentin TE, et al. Among authors: moore jc. Blood. 2000 Sep 1;96(5):1703-8. Blood. 2000. PMID: 10961867 Free article.

3

Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

Warkentin TE, Cook RJ, Marder VJ, Sheppard JA, Moore JC, Eriksson BI, Greinacher A, Kelton JG. Warkentin TE, et al. Among authors: moore jc. Blood. 2005 Dec 1;106(12):3791-6. doi: 10.1182/blood-2005-05-1938. Epub 2005 Aug 18. Blood. 2005. PMID: 16109780 Free PMC article. Clinical Trial.

4

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?

Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. Warkentin TE, et al. Among authors: moore km, moore jc. J Lab Clin Med. 2005 Dec;146(6):341-6. doi: 10.1016/j.lab.2005.08.003. J Lab Clin Med. 2005. PMID: 16310517 Clinical Trial.

5

Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.

Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Warkentin TE, et al. Among authors: moore jc. J Thromb Haemost. 2008 Aug;6(8):1304-12. doi: 10.1111/j.1538-7836.2008.03025.x. Epub 2008 May 17. J Thromb Haemost. 2008. PMID: 18489711 Free article.

6

FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.

Nazi I, Arnold DM, Smith JW, Horsewood P, Moore JC, Warkentin TE, Crowther MA, Kelton JG. Nazi I, et al. Among authors: moore jc. J Thromb Haemost. 2013 Jun;11(6):1146-53. doi: 10.1111/jth.12208. J Thromb Haemost. 2013. PMID: 23551961 Free article.

7

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.

Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM. Nazy I, et al. Among authors: moore jc. J Thromb Haemost. 2018 Jul;16(7):1402-1412. doi: 10.1111/jth.14132. Epub 2018 Jun 5. J Thromb Haemost. 2018. PMID: 29723924 Free article.

8

Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT).

Warkentin TE, Sheppard JI, Smith JW, Li N, Moore JC, Arnold DM, Nazy I. Warkentin TE, et al. Among authors: moore jc. J Thromb Haemost. 2020 Jun;18(6):1435-1446. doi: 10.1111/jth.14794. Epub 2020 Apr 27. J Thromb Haemost. 2020. PMID: 32167669 Free PMC article.

9

Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.

Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM. Nazy I, et al. Among authors: moore jc. J Thromb Haemost. 2021 May;19(5):1342-1347. doi: 10.1111/jth.15283. Epub 2021 Mar 14. J Thromb Haemost. 2021. PMID: 33639037 Free PMC article.

10

Serum-induced platelet procoagulant activity: an assay for the characterization of prothrombotic disorders.

Warner MN, Pavord S, Moore JC, Warkentin TE, Hayward CP, Kelton JG. Warner MN, et al. Among authors: moore jc. J Lab Clin Med. 1999 Feb;133(2):129-33. doi: 10.1016/s0022-2143(99)90005-7. J Lab Clin Med. 1999. PMID: 9989764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters